The commercialization of the biomedical sciences: (mis)understanding bias. Academic Article uri icon

Overview

abstract

  • The growing commercialization of scientific research has raised important concerns about industry bias. According to some evidence, so-called industry bias can affect the integrity of the science as well as the direction of the research agenda. I argue that conceptualizing industry's influence in scientific research in terms of bias is unhelpful. Insofar as industry sponsorship negatively affects the integrity of the research, it does so through biasing mechanisms that can affect any research independently of the source of funding. Talk about industry bias thus offers no insight into the particular epistemic shortcomings at stake. If the concern is with the negative effects that industry funding can have on the research agenda, conceptualizing this influence as bias obscures the ways in which such impact is problematic and limits our ability to offer solutions that can successfully address the concerns raised by the growing role of private funding in science.

publication date

  • September 4, 2019

Research

keywords

  • Biomedical Research
  • Commodification
  • Technology Transfer

Identity

Scopus Document Identifier

  • 85071757590

Digital Object Identifier (DOI)

  • 10.1007/s40656-019-0274-x

PubMed ID

  • 31485872

Additional Document Info

volume

  • 41

issue

  • 3